Cryptic peptides have intermediate binding affinity toward MHC; therefore, clonal T cell deletion does not occur or only occurs rarely, thus retaining a large TCR repertoire (Menez-Jamet J, et al. Optimized tumor cryptic peptides: the basis for universal neo-antigen-like tumor vaccines. Here, HLA-C is linked to neoplasm.